Skip to main content

Table 1 Summary of clinical and laboratory data

From: Maturity-onset diabetes of the young secondary to HNF1B variants (HNF1B-MODY): a series of 10 patients from a single diabetes center

Patient

1

2

3

4

5

6

7

8

9

10

Case

Index

Familial

Index

Familial

Index

Index

Index

Index

Familial

Index

Sex

Female

Male

Female

Female

Female

Female

Male

Male

Female

Male

Genotype

c.827G > Ap.(Arg276Gln)

c.827G > Ap.(Arg276Gln)

c.1-?_1674 + ? del

c.1-?_1674 + ? del

c.1147C > T p.(Gln383*)

c.988C > Tp.(Leu330Phe)

c.494G > Ap.(Arg165His)

c.526C > Tp.(Gln176*)

c.526C > Tp.(Gln176*)

c.493C > Tp.(Arg165Cys)

BMI (kg/m2)a

26.4

25.3

22.0

24.5

26.7

19.5

20,4

31.0

28.4

27.1

Current age (y/o)

49

46

41

72

30

59

29

41

61

47

Age at MODY diagnosis (y/o)

42

39

35

69

29

58

28

38

60

42

Age at diabetes diagnosis (y/o)

28

28

21

42

29

49

9

13

40

16

Diabetes evolution time (y)

21

18

20

30

1

10

20

28

21

31

Current diabetestreatment

Insulin

Insulin

Insulin

Insulin

Oral agents

Insulin

Insulin

Insulin

Insulin

Insulin

Complications (renal not included)

DRb

None

DR

None

None

None

ICMc

DR, DNd

None

DR, ICM

C-peptide

0.5

0.2

0.5

0.4

2.8

3.8

0.9

0.2

0.3

0.1

HbA1c (%)

6.3

6.5

7.8

7.8

6.2

7.1

9.7

9.5

8.9

9.3

Renal malformation

URHg

SKh

URH

No

Unknown

No

BRHi

No

No

URH

Transplantation

Kidney

Kidney

Liver

No

No

Kidney

No

No

Kidney

Pancreas

No

Kidney

Pancreas

CKD

Yes

Yes

Yes

No

Yes

No

Yes

Yes

Yes

Yes

CKD prior to diabetes (years)

13

20

10

16

1

CKD after diabetes (years)

2

19

5

eGFRf

77

55

HD

52

76

99

17

51

30

17

Albumin urinary excretion

Y

Y

N/A

N

N

N

N/A

Y

N

Y

Hypertension

Y

Y

Y

Y

N

Y

Y

Y

Y

Y

Elevated liver enzymes

Y

Y

N

N

N

N

N

N

Y

Y

Hypomagnesemia

N

N

N

N

Y

N

N

N

N

N

Hyperuricemia

Y

Y

N

N

Y

N

N

N

Y

Y

Reproductive tract malformation

N

N/A

N

N

Y

N

N/A

N/A

N

N/A

  1. aBMI body mass index was calculated based on anthropometric measurements from the last observation, bDR diabetic retinopathy, cICM ischemic cardiomyopathy, ddiabetic neuropathy, eC-peptide plasma concentration: reference range 0.9–7.1 ng/mL, feGFR estimated glomerular filtration rate (ml/min/1.73 m2), gURH unilateral renal hypoplasia, hSK solitary kidney, iBRH bilateral renal hypoplasia